Intraoperative Neuromonitoring Market , by Monitoring Type (Insourced monitoring, Outsourced monitoring), Application (Neuro & spine surgeries, Cardiovascular surgeries, ENT surgeries, Orthopedic surgeries), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026
- RES4072113
- 120 Pages
- March 2020
- Healthcare
Intraoperative neuromonitoring is also called as intraoperative neurophysiological monitoring and is implemented in electro-physiological procedures such as electroencephalography and electromyography. Intraoperative neuromonitoring arrangements play significant role in the controlling and monitoring of practical integrity of various neural constructions including nerves, brain, ENT and spinal cord throughout the operations. The purpose of intraoperative neuromonitoring is to reduce the patient risk during the surgeries.
Intraoperative Neuromonitoring Market Drivers: The global intraoperative neuromonitoring market is significantly driven by aspects such as rising number of aged people globally and rising number of patients suffering from chronic disorders. In addition, rising awareness about intraoperative neuromonitoring systems for patient safety while surgery and increasing in implementation of intraoperative neuromonitoring arrangements by emergency hospitals are anticipated to fuel the market growth. Moreover, increasing acceptance of intraoperative neuromonitoring for various surgeries including orthopedic and ENT will further boost the growth of the market.
Cost of treatment with intraoperative neuromonitoring is very high; it is acting as a limitation for the market growth. Moreover, lack of skilled labor for the monitoring control systems is also expected to hinder the market size.
Growing popularity of medical tourism is projected to create huge investment opportunities in the global intraoperative neuromonitoring market. Moreover, continuous rise in technical improvements in intraoperative neuromonitoring systems is estimated to enhance the market growth in the near future.
The global intraoperative neuromonitoring market is segmented into monitoring type and application.
By monitoring type, the market has been classified into insourced monitoring and outsourced monitoring. In these, outsourced monitoring is estimated to experience a remarkable growth and is expected to reach $1,658.7 million by 2026. The global market has dominated by insourced monitoring; it generated over $1,401.6 million in 2018 and is anticipated to continue its dominance in the coming time.
By application, the market is segmented into neuro & spine surgeries, cardiovascular surgeries, ENT surgeries and orthopedic surgeries. Among these, the market for neuro & spine surgeries segment is expected to lead the global market size and is estimated to continue its growth during the forecast period. Besides neuro & spine surgeries, the market for ENT surgeries and orthopedic surgeries are anticipated to grow at significant rate and estimated to produce enormous growth opportunities in the global market during the estimated time.
Geographically, the global intraoperative neuromonitoring market is analyzed across the regions including North America, Europe, Asia-Pacific and LAMEA. Among these, North America accounted for majority of the intraoperative neuromonitoring market size; it generated $1,231.0 million in 2018 and is projected to register $1,662.1 million in the 2026. The market for Asia-Pacific is predicted to grow at a notable rate of 5.6% CAGR and is estimated to generate major revenue in the coming years.
The key manufacturers in the global intraoperative neuromonitoring market are Cadwell Industries, Inc., NuVasive, Inc., NIHON KOHDEN CORPORATION, IntraNerve Neuroscience Holdings, LLC, Medgadget, Inc., Moberg Research, Inc., Medtronic, Accurate Monitoring, Medsurant Health, NeuroMonitoring Technologies, Inc. and Computational Diagnostics, Inc. The key manufacturers are continuously increasing their efforts to improve the product performance and quality to raise their market share in the global market. These are the most frequent approaches followed by the manufacturers to gain highest market size in the intraoperative neuromonitoring industry.
1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.4.1.Assumptions
1.4.2.Forecast parameters
1.5.Data sources
1.5.1.Primary
1.5.2.Secondary
2.Executive Summary
2.1.360° summary
2.2.Monitoring type trends
2.3.Application trends
3.Market overview
3.1.Market segmentation & definitions
3.2.Key takeaways
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market
3.4.Market dynamics
3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities
3.5.Technology landscape
3.6.Regulatory landscape
3.7.Patent landscape
3.8.Market value chain analysis
3.9.Strategic overview
4.Intraoperative Neuromonitoring Market, by Monitoring type
4.1.Insourced monitoring
4.1.1.Market size and forecast, by region, 2018-2026
4.1.2.Comparative market share analysis, 2018 & 2026
4.2.Outsourced monitoring
4.2.1.Market size and forecast, by region, 2018-2026
4.2.2.Comparative market share analysis, 2018 & 2026
5.Intraoperative Neuromonitoring Market, by Application
5.1.Neuro & spine surgeries
5.1.1.Market size and forecast, by region, 2018-2026
5.1.2.Comparative market share analysis, 2018 & 2026
5.2.Cardiovascular surgeries
5.2.1.Market size and forecast, by region, 2018-2026
5.2.2.Comparative market share analysis, 2018 & 2026
5.3.ENT surgeries
5.3.1.Market size and forecast, by region, 2018-2026
5.3.2.Comparative market share analysis, 2018 & 2026
5.4.Orthopedic surgeries
5.4.1.Market size and forecast, by region, 2018-2026
5.4.2.Comparative market share analysis, 2018 & 2026
6.Intraoperative Neuromonitoring Market, by Region
6.1.North America
6.1.1.Market size and forecast, by monitoring type, 2018-2026
6.1.2.Market size and forecast, by application, 2018-2026
6.1.3.Market size and forecast, by country, 2018-2026
6.1.4.Comparative market share analysis, 2018 & 2026
6.1.5.U.S.
6.1.5.1.Market size and forecast, by monitoring type, 2018-2026
6.1.5.2.Market size and forecast, by application, 2018-2026
6.1.5.3.Comparative market share analysis, 2018 & 2026
6.1.6.Canada
6.1.6.1.Market size and forecast, by monitoring type, 2018-2026
6.1.6.2.Market size and forecast, by application, 2018-2026
6.1.6.3.Comparative market share analysis, 2018 & 2026
6.1.7.Mexico
6.1.7.1.Market size and forecast, by monitoring type, 2018-2026
6.1.7.2.Market size and forecast, by application, 2018-2026
6.1.7.3.Comparative market share analysis, 2018 & 2026
6.2.Europe
6.2.1.Market size and forecast, by monitoring type, 2018-2026
6.2.2.Market size and forecast, by application, 2018-2026
6.2.3.Market size and forecast, by country, 2018-2026
6.2.4.Comparative market share analysis, 2018 & 2026
6.2.5.Germany
6.2.5.1.Market size and forecast, by monitoring type, 2018-2026
6.2.5.2.Market size and forecast, by application, 2018-2026
6.2.5.3.Comparative market share analysis, 2018 & 2026
6.2.6.UK
6.2.6.1.Market size and forecast, by monitoring type, 2018-2026
6.2.6.2.Market size and forecast, by application, 2018-2026
6.2.6.3.Comparative market share analysis, 2018 & 2026
6.2.7.France
6.2.7.1.Market size and forecast, by monitoring type, 2018-2026
6.2.7.2.Market size and forecast, by application, 2018-2026
6.2.7.3.Comparative market share analysis, 2018 & 2026
6.2.8.Spain
6.2.8.1.Market size and forecast, by monitoring type, 2018-2026
6.2.8.2.Market size and forecast, by application, 2018-2026
6.2.8.3.Comparative market share analysis, 2018 & 2026
6.2.9.Italy
6.2.9.1.Market size and forecast, by monitoring type, 2018-2026
6.2.9.2.Market size and forecast, by application, 2018-2026
6.2.9.3.Comparative market share analysis, 2018 & 2026
6.2.10.Rest of Europe
6.2.10.1.Market size and forecast, by monitoring type, 2018-2026
6.2.10.2.Market size and forecast, by application, 2018-2026
6.2.10.3.Comparative market share analysis, 2018 & 2026
6.3.Asia Pacific
6.3.1.Market size and forecast, by monitoring type, 2018-2026
6.3.2.Market size and forecast, by application, 2018-2026
6.3.3.Market size and forecast, by country, 2018-2026
6.3.4.Comparative market share analysis, 2018 & 2026
6.3.5.China
6.3.5.1.Market size and forecast, by monitoring type, 2018-2026
6.3.5.2.Market size and forecast, by application, 2018-2026
6.3.5.3.Comparative market share analysis, 2018 & 2026
6.3.6.India
6.3.6.1.Market size and forecast, by monitoring type, 2018-2026
6.3.6.2.Market size and forecast, by application, 2018-2026
6.3.6.3.Comparative market share analysis, 2018 & 2026
6.3.7.Japan
6.3.7.1.Market size and forecast, by monitoring type, 2018-2026
6.3.7.2.Market size and forecast, by application, 2018-2026
6.3.7.3.Comparative market share analysis, 2018 & 2026
6.3.8.Australia
6.3.8.1.Market size and forecast, by monitoring type, 2018-2026
6.3.8.2.Market size and forecast, by application, 2018-2026
6.3.8.3.Comparative market share analysis, 2018 & 2026
6.3.9.Rest of Asia Pacific
6.3.9.1.Market size and forecast, by monitoring type, 2018-2026
6.3.9.2.Market size and forecast, by application, 2018-2026
6.3.9.3.Comparative market share analysis, 2018 & 2026
6.4.LAMEA
6.4.1.Market size and forecast, by monitoring type, 2018-2026
6.4.2.Market size and forecast, by application, 2018-2026
6.4.3.Market size and forecast, by country, 2018-2026
6.4.4.Comparative market share analysis, 2018 & 2026
6.4.5.Latin America
6.4.5.1.Market size and forecast, by monitoring type, 2018-2026
6.4.5.2.Market size and forecast, by application, 2018-2026
6.4.5.3.Comparative market share analysis, 2018 & 2026
6.4.6.Middle East
6.4.6.1.Market size and forecast, by monitoring type, 2018-2026
6.4.6.2.Market size and forecast, by application, 2018-2026
6.4.6.3.Comparative market share analysis, 2018 & 2026
6.4.7.Africa
6.4.7.1.Market size and forecast, by monitoring type, 2018-2026
6.4.7.2.Market size and forecast, by application, 2018-2026
6.4.7.3.Comparative market share analysis, 2018 & 2026
7.Company profiles
7.1.NuVasive, Inc.
7.1.1.Business overview
7.1.2.Financial performance
7.1.3.Product portfolio
7.1.4.Recent strategic moves & developments
7.1.5.SWOT analysis
7.2.Computational Diagnostics, Inc.
7.2.1.Business overview
7.2.2.Financial performance
7.2.3.Product portfolio
7.2.4.Recent strategic moves & developments
7.2.5.SWOT analysis
7.3.NIHON KOHDEN CORPORATION
7.3.1.Business overview
7.3.2.Financial performance
7.3.3.Product portfolio
7.3.4.Recent strategic moves & developments
7.3.5.SWOT analysis
7.4.Moberg Research, Inc.
7.4.1.Business overview
7.4.2.Financial performance
7.4.3.Product portfolio
7.4.4.Recent strategic moves & developments
7.4.5.SWOT analysis
7.5.Medsurant Health
7.5.1.Business overview
7.5.2.Financial performance
7.5.3.Product portfolio
7.5.4.Recent strategic moves & developments
7.5.5.SWOT analysis
7.6.Cadwell Industries, Inc.
7.6.1.Business overview
7.6.2.Financial performance
7.6.3.Product portfolio
7.6.4.Recent strategic moves & developments
7.6.5.SWOT analysis
7.7.Medtronic
7.7.1.Business overview
7.7.2.Financial performance
7.7.3.Product portfolio
7.7.4.Recent strategic moves & developments
7.7.5.SWOT analysis
7.8.Medgadget, Inc.
7.8.1.Business overview
7.8.2.Financial performance
7.8.3.Product portfolio
7.8.4.Recent strategic moves & developments
7.8.5.SWOT analysis
7.9.IntraNerve Neuroscience Holdings, LLC
7.9.1.Business overview
7.9.2.Financial performance
7.9.3.Product portfolio
7.9.4.Recent strategic moves & developments
7.9.5.SWOT analysis
7.10.Accurate Monitoring
7.10.1.Business overview
7.10.2.Financial performance
7.10.3.Product portfolio
7.10.4.Recent strategic moves & developments
7.10.5.SWOT analysis
7.11.NeuroMonitoring Technologies, Inc.
7.11.1.Business overview
7.11.2.Financial performance
7.11.3.Product portfolio
7.11.4.Recent strategic moves & developments
7.11.5.SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
